This inventor holds 2 USPTO granted patents. Top assignees: Jiangnan University, Max Planck Institute of Colloids and Interfaces. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Innovations of Zhou Ye in Biomedicine
Introduction
Zhou Ye is a prominent inventor based in Wuxi, China, known for his contributions to the field of biomedicine. He holds two patents that focus on advanced materials and systems for targeted therapies, particularly in the treatment of liver tumors. His work integrates innovative approaches to enhance the efficacy of photodynamic therapy and drug delivery systems.
Latest Patents
Zhou Ye's latest patents include the "Preparation and application of novel multifunctional nanocomposite material with new photosensitizer." This patent discloses a multifunctional nanocomposite material designed for photodynamic therapy, specifically targeting liver tumor cells. The material is created through the self-assembly of cercosporin and an acid-sensitive copolymer, which allows for targeted delivery and release of the photosensitizer under acidic conditions. His second patent, "Integrated nano system for liver-targeting co-delivery of genes/drugs and preparation method," presents a drug delivery system that combines gene and drug therapies. This system utilizes a biocompatible carrier and pH-responsive copolymers to enhance therapeutic outcomes.
Career Highlights
Zhou Ye has worked at notable institutions such as Jiangnan University and the Max Planck Institute of Colloids and Interfaces. His research has significantly advanced the understanding and application of nanocomposite materials in medicine.
Collaborations
Some of his notable coworkers include Jian Yin and Jing Hu, who have contributed to his research endeavors and innovations in the field.
Conclusion
Zhou Ye's innovative work in biomedicine, particularly in the development of targeted therapies for liver tumors, showcases his commitment to advancing medical technology. His patents reflect a significant step forward in the integration of nanotechnology and medicine, promising improved treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile